Denna sida på svenska
Loading profile information...

About me

I am an epidemiologist and doctor of medicine that seeks to be part of an interdisciplinary, highly qualified and ambitious team, working with epidemiology, statistics, genomics, metabolic and cardiovascular diseases, where I can learn, develop, and contribute with my skills and expertise to the team.


  • PhD candidate, Epidemiology, KI (current)
  • Graduate student from the SINGS, KI (2014)
  • MSc, Global Health, KI (2012)
  • MD, University of Cauca, Colombia (2011)

Research description

Thesis title: Postmenopausal Hormone Therapy and Cardiovascular Risk.

The project was designed with the aim to increase the knowledge about postmenopausal hormone therapy and its possible influence on risk of developing cardiovascular disease in menopausal women. The project was based on observational data from a case-control study and from a pooling of individual participant raw data from five cohort studies.

I worked in connection with researchers at Karolinska Institutet to establish the COMPREHEND project database ( This project involved collaboration across different regions from Sweden where individual participant data was collected for over 80,000 postmenopausal women.


Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
Carrasquilla Gd, Frumento P, Berglund A, Borgfeldt C, Bottai M, Chiavenna C, et al
PLoS medicine 2017;14(11):e1002445-

Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study
Carrasquilla Gd, Berglund A, Gigante B, Landgren Bm, De Faire U, Hallqvist J, et al
Menopause (New York, N.Y.) 2015;22(6):598-606

The association between menopausal hormone therapy and coronary heart disease depends on timing of initiation in relation to menopause onset. Results based on pooled individual participant data from The Combined Cohorts of Menopausal Women - Studies of Register Based Health Outcomes in Relation to Hormonal Drugs (COMPREHEND) study
Carrasquilla Gd, Chiavenna C, Bottai M, Magnusson Pk, Santacatterina M, Wolk A, et al